Head-to-head · WeighScore
Lighter You vs Strut Health
The verdict
Strut Health takes it — 79.4/100 to 74.3/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Lighter You | Strut Health |
|---|---|---|
| WeighScore | 74.3/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #69 | #28 |
| Semaglutide | $169 per 4 weeks (store and intake price; thirteen charges a year) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | $339 per 4 weeks (store and intake price; the marketing site advertises $169) | From $199/mo either route |
| Coverage | All 50 states plus Washington, D.C. (claimed; the footer says otherwise) | 49 states (not Arkansas) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Site position #69 · C
Strengths
- The store and the intake agree with each other, so a reader who starts at the store sees the figure that will be charged
- Names four dispensing pharmacies with addresses and phone numbers
- Runs oral, microdose and injectable GLP-1 lines plus a separate peptide sub-brand, so the menu is unusually wide for the price band
- Unlimited video visits and dietitian check-ins are described as included in every plan
- A full refund is offered if a clinician declines the prescription
Where it loses points
- Tirzepatide is advertised at $169 a month on the marketing site and sold at $339 per four weeks in the store and the intake
- The marketing site says “/mo” and the store bills per four weeks, which is thirteen charges a year rather than twelve
- GLP-1 tablets are advertised at $249 and sold at $279 per four weeks; microdosing is advertised at $96 and sold at $179
- The peptide sub-brand prices the same products differently again — NAD+ at $199 against $229, sermorelin at $175 against $229
- The Terms claim all 50 states plus Washington, D.C. and the footer on the same site says not available in all 50 states
- No clinician, medical group or NPI is named, and no compounding class appears anywhere on the domain
- A dietitian visit is promised on the homepage with an asterisk that resolves to no footnote, and neither the Terms nor the refund policy promises one
Site position #28 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
Where it loses points
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring program
- Compounded only, with no brand-name lane
- Not available in Arkansas
Featured provider
Strut Health
Strut Health scores 79.4/100 (C+). The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.